LincR-PPP2R5C编码的微肽TREMP调控CD4+T细胞分化介导哮喘发生发展的机制研究
批准号:
81970031
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
黄茂
依托单位:
学科分类:
支气管哮喘
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
黄茂
中文摘要
长链非编码RNA(lncRNA)编码的微肽在哮喘中作用未知。我们前期发现LincR-PPP2R5C的短开放阅读框架6(sORF6)可以编码微肽,促进Th2分化;体内转染sORF6后哮喘加重,2型细胞因子增多;LincR-PPP2R5C-sORF6暂命名为T细胞调控微肽(TREMP);TREMP与哺乳动物雷帕霉素靶蛋白(mTOR)同源;TREMP过表达影响mTOR通路;质谱分析提示TREMP可结合细胞骨架相关蛋白4 (CKAP4);CAKP4激活mTOR通路并促进IL-33分泌。我们推测:TREMP结合CAKP4调控mTOR通路、增加IL-33表达从而促进Th2分化,介导过敏性哮喘的发生发展。本项目拟构建病毒载体、全敲除和CD4+T细胞条件性敲除小鼠以及TREMP单克隆抗体等,考察TREMP在哮喘发生发展中的作用。上述研究能加深理解lncRNA的编码潜能以及CD4+T细胞在哮喘中的分化机制。
英文摘要
Roles of micropeptide encoded by long non-coding RNA (lncRNA) in the differentiation of CD4+T cells from allergic asthma remain largely elusive. In preliminary experiments, LincR-PPP2R5C contributed to CD4+ T cells differentiation in allergic asthma. The short Open Reading Frame 6 (sORF6) from LincR-PPP2R5C encodes a micropeptide, which regulates the T cells differentiation. We name sORF6 micropeptide TREMP (T cell regulatory micropeptide). In vitro, TREMP promotes Th2 differentiation. In vivo, TREMP aggravates asthma and type 2 cytokines in the mouse model of acute asthma. TREMP shares evolutionary similarity with mammalian target of Rapamycin (mTOR). In vitro and in vivo, TREMP over-expression affects the mTOR pathway. Mass Spectrometry analysis reveals that TREMP may interact with Cytoskeleton-associated protein 4 ( CKAP4), which activates mTOR pathway and increases IL-33 secretion. Therefore, we postulate the hypothesis that LincR-PPP2R5C encodes micropeptide TREMP may regulate the Th2 differentiation via CKAP4-mTOR-IL-33 in allergic asthma. To explore the above hypothesis, we would (1) construct lentivirus system, which aims to over-expressing or silencing TREMP in the CD4+ T cells; (2) knockout TREMP in the mouse or conditionally knockout TREMP in the CD4+ T cells in vivo; (3) produce TREMP monoclonal antibody and test its function in the CD4+T cells differentiation and asthma. Our work would of great value in the exploring the roles of lncRNA encodes novel micropeptide in the differentiation of CD4+ T cells in allergic asthma.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Current status of prevention and treatment of respiratory diseases in primary care in China: a cross-sectional study.
中国基层呼吸系统疾病防治现状:横断面研究
DOI:
10.1186/s12890-022-01956-6
发表时间:
2022-04-24
期刊:
BMC pulmonary medicine
影响因子:
3.1
作者:
[]
通讯作者:
Characteristics of H7N9 avian influenza pneumonia: a retrospective analysis of 17 cases
H7N9禽流感肺炎17例病例回顾性分析
DOI:
10.1111/imj.14685
发表时间:
2019-11
期刊:
Internal Medicine Journal
影响因子:
2.1
作者:
[Wen-Qing Yu, Ning-Fei Ji, Ming-Dong Ding, Yuan Ma, Da-Ming Zhou, Yan Chen, Zhu Yang, Zhen-Zhen Wu, Cheng-Jing Gu, Gui-Hong Dai, Rong-Rong Jin, Jian-Chun Xian, Chao-Jie Wu, Yan-Li Wang, Yi-Bin Tan, Hong-Tao Xu, Mao Huang]
通讯作者:
Mao Huang
DOI:
--
发表时间:
2020
期刊:
江苏医药
影响因子:
作者:
[朱然然, 吴桢珍, 解卫平, 刘扣英, 黄茂]
通讯作者:
黄茂
DOI:
10.1186/s13223-022-00697-9
发表时间:
2022-06-19
期刊:
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.7507/1671-6205.202204066
发表时间:
2022
期刊:
中国呼吸与危重监护杂志
影响因子:
作者:
[蒋素妹, 马元, 王正霞, 黄茂]
通讯作者:
黄茂
共 14 条
LincR-PPP2R5C靶向调控ARNT/PP2A/STAT3和吸附miRNA介导Th2细胞分化参与支气管哮喘发生发展
-
批准号:81770031
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2017
-
负责人:黄茂
-
依托单位:
国内基金
海外基金